GLP-1s have been on the market for years now, with as many as 1 in 8 adult Americans using them at some point. And what’s clear, and fascinating, is that the side effects I’m hearing about are evolving.
Robin’s Short Version
- 18% of GLP-1 users reported increased sexual desire and 16% reported decreased desire — effects running almost equally in both directions.
- GLP-1 receptors are expressed throughout the brain’s reward circuitry — including the nucleus accumbens and ventral tegmental area (VTA), the same structures that govern sexual desire, motivation, and the will to pursue anything.
- Exercise — especially vigorous exercise — is one of the most powerful dopamine-boosting tools we have.
Not nausea. Not even the muscle loss issue. It’s quieter than that. A patient of mine who used to be driven, ambitious, deeply present in her marriage… says she feels fine. But… a little flat, as if she is disconnected or "offline."
Another patient who had suffered for years from binge eating disorder. Constant food obsession. Food taking up enormous real estate in his head. Since starting Semaglutide, that mental noise is gone. He’s more present with his kids. More focused at work. He says it gave him his life back.
Both of these experiences are real. Both are happening with the same drug class.
This week, I unpack what’s going on in the brain on these drugs, whether or not this hyped phenomenon of motivation loss is real — and what we still don’t know.
If you’re on a GLP-1 and noticing mood, motivation, or desire shifts — or wondering whether to start one — this is exactly what I’d want to look at with you: your testosterone, estrogen, thyroid, and full metabolic picture alongside the drug. Let’s look at the whole story →
🤓 What to know: Your hunger and your libido share the same wiring.
❌ The old assumption: GLP-1 drugs work in the gut and pancreas. Their effects on appetite are peripheral. The brain is mostly incidental.
✅ The new reality: GLP-1 receptors are expressed throughout the brain’s reward circuitry — including the nucleus accumbens and ventral tegmental area (VTA), the same structures that govern sexual desire, motivation, and the will to pursue anything.
Food, sex, achievement, connection — these are not separate drives. They run on the same dopamine infrastructure.
🧠 Hunger and desire are primordially linked. The mesolimbic dopamine system — your brain’s core "wanting" circuit — evolved to drive pursuit of survival rewards: food, mates, connection, status. Hunger and sexual desire both rely on the same dopaminergic "wanting" signal. When you modulate one, you touch all of them.
🔬 What the research actually says — which is: not much, yet. The only randomized controlled trial on GLP-1s and sexual desire used 24 lean healthy men on dulaglutide for four weeks. That’s it. It found no effect on libido. But that study tells us almost nothing about overweight women on semaglutide for a year — which is who is mostly taking these drugs [1].
A Kinsey Institute survey of 2,000 adults found that among GLP-1 users, 18% reported increased sexual desire and 16% reported decreased desire — effects running almost equally in both directions [2]. The FDA adverse event database has flagged 182 cases of GLP-1-associated sexual dysfunction since 2003 — a weak signal [3].
18% of GLP-1 users reported increased sexual desire. 16% reported decreased desire. The effects run almost equally in both directions — which tells you this is not a simple story.
📉 The serotonin mechanism — real, but complicated. GLP-1s activate the 5-HT2C serotonin receptor. This is the same pathway through which SSRIs reduce libido. Theoretically, this could suppress sexual desire. But weight loss itself raises testosterone, improves vascular function, and boosts mood — all of which push libido up. The two forces may cancel out for many people, and tip one way or the other depending on the individual [4].
🤷 The honest bottom line: We don’t know. There isn’t enough research on women. Long-term data doesn’t exist. What we do know is that these drugs reach reward circuits we haven’t fully mapped — and the individual variation in response is enormous.
💪 What to do: Track your desire like a biomarker.
1️⃣ Establish a baseline before you start.
Before your first dose, answer these honestly: Where is my libido right now? Where is my drive and motivation? How much joy and enthusiasm do I feel about my work, relationships, and daily life? Write it down. These are your benchmark numbers.
2️⃣ Do a weekly check-in — seriously, write it down.
I can’t remember what I had for lunch last Tuesday, let alone what my motivation for work was a month ago. Writing it down is key. So once a week, take 5 minutes and journal: What has changed since I started the GLP-1? Is my motivation higher or lower? My sexual desire? My emotional availability? My drive to pursue things I care about? Patterns only emerge over time.
3️⃣ Don’t assume your experience will match someone else’s.
Different GLP-1s hit brain receptors differently. What flattens one person’s desire may free up another’s. Semaglutide ≠ tirzepatide ≠ liraglutide. If you’re experiencing unwanted blunting on one, a different formulation — or a different dose — may not have the same effect.
4️⃣ Assess for other brakes on the gas.
If you’re feeling flat on a GLP-1, it’s worth asking: was I already flat before? Are there other factors sitting on the brake of my desire and motivation — undiagnosed or undertreated ADHD, anxiety, complex feelings in a relationship, burnout, low testosterone or estrogen, thyroid issues? The GLP-1 may not be the only story.
5️⃣ Protect your dopamine system with vigorous exercise.
Exercise — especially vigorous exercise — is one of the most powerful dopamine-boosting tools we have. So is consistent, high-quality sleep. Both support the reward circuitry that GLP-1s may be modulating. Both are evidence-backed. If you’re on a GLP-1, these aren’t optional extras. They’re protective.
6️⃣ If something feels off, say something.
The field is moving fast. Clinicians need to know when patients experience changes in mood, libido, or motivation on these drugs. This data drives future research. Don’t minimize it. Report it.
⭐ If you do one thing: Establish your baseline before your first dose — libido, motivation, enthusiasm, drive, all of it. Write it down. You can’t track what you didn’t measure.
The goal: You don’t have to choose between metabolic health and a full, desire-driven life. But you do have to pay attention.
💛 The Momgevity Files
When did all the moms get hot?
This was posed by a male Instagram creator whose videos on his experience with his wife in perimenopause are deadpan and very funny. This one made me laugh — and it reminded me of a comment a male friend made recently about a woman we know being "super hot for a mom." I told him: you probably need to reframe what a mom is and what she looks like.
Another joke I’m hearing a lot lately is that my beloved millennial generation is hitting perimenopause and we are not going down without a fight — holding on to our 2000s tube-top party days come hell or high water. Truth! In my case, my abs at 44 are way worthier of a tube top than my abs at 24. Just saying. 😉
I also hear from countless women in their late 30s and 40s that their sex drive is way up after kids — not down — and they’re surprised, as if they assumed that once their fertile years were behind them, desire would just wither away.
We’ve absorbed a lot of silly programming. It feels like time to undo it.
What I see in practice — with patients, with friends, and in my own life — is that the perimenopause and midlife experience today looks nothing like our mental model. Women are looking and feeling amazing. Fit, energized, in their prime. Their drive isn’t slowing down — in career or in bed. If anything, they’re liberated from the assumptions, judgments, and fears that held their younger selves back. More fully expressed than ever, they’re free to embody their truest desires.
The fact is, what good is longevity if you don’t know what you want? Or you’re too afraid to have it? The best part of getting older, I’m finding, is clarity — on what I want, comfort in my own body and skin, and a refusal to uphold anything that isn’t true to me, regardless of consequence.
I think women at this age and phase of life were always hot. But this generation of millennials — myself included — are embracing and embodying it more than ever, reshaping what it means to be a woman, and a mom, in the process.
Does this resonate? Have you noticed changes in drive or desire on a GLP-1 — or know someone who has? Hit reply.
Stay strong, stay curious, and breathe,
Robin
Frequently Asked Questions
Do GLP-1s like Ozempic decrease libido?
The evidence is genuinely mixed. A Kinsey Institute survey of 2,000 adults found 18% of GLP-1 users reported increased sexual desire and 16% reported decreased desire — effects running almost equally in both directions. The FDA adverse event database has flagged 182 cases of GLP-1-associated sexual dysfunction since 2003, which is a weak signal, not a clear causal link.
How do GLP-1s affect motivation and reward in the brain?
GLP-1 receptors are expressed throughout the brain’s reward circuitry — including the nucleus accumbens and ventral tegmental area (VTA), the same structures that govern sexual desire, motivation, and the will to pursue anything. Food, sex, achievement, and connection all run on the same dopamine infrastructure, so when you modulate one drive, you touch all of them.
How do I track libido and motivation changes on a GLP-1?
I recommend establishing a written baseline before your first dose — rate your libido, drive, motivation, and enthusiasm on a 1–10 scale. Then do a weekly journal check-in for at least 3 months. You can’t track what you didn’t measure, and patterns only emerge over time.
Is semaglutide different from tirzepatide for libido effects?
Different GLP-1s hit brain receptors differently, and what flattens one person’s desire may free up another’s — semaglutide ≠ tirzepatide ≠ liraglutide. If you’re experiencing unwanted blunting on one formulation, a different drug or dose may not have the same effect. This is exactly the kind of individual variation worth discussing with your clinician.
Scientific References
- EBioMedicine, 2024 — GLP-1 receptors in brain reward circuits and desire
- Kinsey Institute, 2025 — Survey of 2,000 adults on GLP-1 sexual desire effects
- International Journal of Impotence Research, 2025 — FDA adverse events GLP-1 sexual dysfunction
- Journal of Sexual Medicine, 2025 — Serotonin 5-HT2C pathway and libido on GLP-1s
